159 results
8-K
KA
Kineta Inc
12 Mar 24
Partial response and stable disease reported in combination cohort, and durable stable disease observed in monotherapy cohorts
8:05am
and there can be no assurance that such activities will result in any agreements or transactions that will enhance stockholder value. Evaluating … that require stockholder approval may not be approved by Kineta’s stockholders.
There can be no assurance that Kineta’s process to identify and evaluate
8-K
KA
Kineta Inc
30 Aug 19
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:05pm
. The Company expects that its stock would remain listed pending the Panel’s decision. There can be no assurance that, if the Company does appeal the Staff’s … on Nasdaq. There can be no assurance that the Company will be able to regain compliance with the minimum closing bid price requirement
8-K
EX-1.1
KA
Kineta Inc
9 May 19
Entry into a Material Definitive Agreement
8:07am
. The Company acknowledges and agrees that (i) there can be no assurance that HCW will be successful in selling Placement Shares, and (ii) HCW will incur … in, and otherwise in accordance with, the terms of such Placement Notice. The Company acknowledges and agrees that (i) there can be no assurance